Impact of COVID-19 on pregnant women with Rheumatic heart disease or Peripartum cardiomyopathy

Autor: Arundhati Tilve, Smita D. Mahale, Ankita Pandey, Bhargavi Jnanananda, Niraj N Mahajan, Rahul K. Gajbhiye, Sangram Gadekar
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Adult
medicine.medical_specialty
Fetal Membranes
Premature Rupture
Peripartum cardiomyopathy
Heart disease
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Perinatal Death
Short Communication
Pregnancy Complications
Cardiovascular
03 medical and health sciences
Young Adult
0302 clinical medicine
Pregnancy
Obstetrics and Gynaecology
medicine
Humans
Abnormalities
Multiple
030212 general & internal medicine
Pregnancy Complications
Infectious
Preterm delivery
030219 obstetrics & reproductive medicine
Obstetrics
business.industry
Infant
Newborn
Rheumatic Heart Disease
Obstetrics and Gynecology
COVID-19
Infant
Low Birth Weight
medicine.disease
Low birth weight
Reproductive Medicine
Echocardiography
Premature Birth
Female
Neonatal death
medicine.symptom
business
Cardiomyopathies
Zdroj: European Journal of Obstetrics, Gynecology, and Reproductive Biology
European Journal of Obstetrics & Gynecology and Reproductive Biology
ISSN: 1872-7654
0301-2115
Popis: Highlights • Pregnancy with heart disease is considered a high risk pregnancy due to higher morbidity and mortality Heart disease (RHD/PPCM) was reported in 1% of pregnant and/ post-partum women infected with SARS-CoV-2. • Preterm delivery, PPROM, low birth weight, neonatal death was observed in women with heart disease and COVID-19. • Healthcare system should be strengthened for management of heart disease and COVID-19.
Databáze: OpenAIRE
Externí odkaz: